UK markets closed
NIKKEI 225
38,236.07 -38.03 (-0.10%) HANG SENG
18,475.92 +268.82 (+1.48%) CRUDE OIL
78.51 +0.40 (+0.51%) GOLD FUTURES
2,310.50 +1.90 (+0.08%) DOW
38,675.68 +449.98 (+1.18%) Bitcoin GBP
51,157.02 +247.23 (+0.49%)
Roche Holding AG (RHHBF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 02:48PM EDT
| Previous close | 259.00 |
| Open | 259.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 259.00 - 259.00 |
| 52-week range | 243.42 - 354.00 |
| Volume | |
| Avg. volume | 211 |
| Market cap | 192.543B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 16.58 |
| EPS (TTM) | 15.62 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 10.86 (4.19%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.